Vaccines & Drugs Industry: COVID-19 Implications, Market Assessment, Pipeline, Players and Outlook to 2025

Dublin, May 26, 2020 (GLOBE NEWSWIRE) — The “COVID-19 Impact on Vaccines & Drugs Market – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
The global COVID-19 vaccines market is projected to reach USD 1,401 million by 2025 from USD 2,273 million in 2022, at a CAGR of -14.9% during the forecast period. The growth of the global COVID-19 vaccines market is majorly attributed to the increasing number of people infected with COVID-19 and growing funding for vaccine development.Furthermore, collaborations between global organizations and governments of various nations to promote the supply of essential drugs and medical supplies will fuel market growth. However, factors such as herd immunity, and uncertainty over the efficacy of vaccines and drugs are expected to hinder the market growth.mRNA-1273 from ModernaAd5-nCoV from CanSino BiologicsINO-4800 from InovioLV-SMENP-DC and pathogen-specific aAPC from Shenzhen Geno-Immune Medical InstituteFunding from global governments and foundations is promoting the growth of the marketRemdesivirChloroquine and hydroxychloroquineLopinavir and ritonavir (and that same combination plus interferon-beta)An immune system messenger that can help stop the multiplication of virusesResearchers and physicians in several countries are focusing on various other existing drugs to examine their potential to treat COVID-19. Chinese authorities, which have been dealing with the virus longer, are recommending Arbidol (umifenovir), which has not been approved in Western countries, as well as old antivirals ribavirin and interferon-alpha. Similarly, Avigan (favipiravir) by Fujifilm has shown promise in the treatment of COVID-19.Some of the major players in the COVID-19 vaccines market include Pfizer Inc. (US), Johnson & Johnson Services, Inc (US), GlaxoSmithKline plc. (UK), Sanofi (France) Serum Institute of India (India), among others. Major players in the COVID-19 drugs market include Gilead Sciences, Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Merck KGaA (Germany), and Janssen Pharmaceuticals, Inc. (Belgium), among others.Research CoverageThis report describes and studies the global COVID-19 vaccines and drugs market, current pipeline of vaccines and drugs by phase by companies, competitive landscape, a viewpoint on COVID-19 pipeline, the impact of COVID-19 on other vaccines and drugs in the portfolio/other under development vaccines and drugs, macroeconomic indicators (drivers, restraints, new opportunities), post-COVID-19 approval scenario, challenges in approval/production/supply, strategies to overcome challenges, historical examples (SARS, MERS, Ebola, H1N1), new strategies, strategies to ramp up production at pandemic level, historical examples, and new strategies.This report provides insights into the following pointers:Market Penetration: Comprehensive information on the developmental pipeline of the top players in the COVID-19 vaccines and drugs market. The report analyzes the current pipeline of vaccines and drugs by phase by companies, competitive landscape, a viewpoint on COVID-19 pipeline, the impact of COVID-19 on other vaccines, and drugs in the portfolio/other under development vaccines and drugs and regional analysis.Product Development/Innovation: Detailed insights on upcoming vaccines and drugs based on innovative technologies, research and development activities, and product launches in the COVID-19 vaccines and drugs market.Market Development: Comprehensive information about lucrative markets. The report analyzes the markets for vaccines and drugs across regions.Market Diversification: Exhaustive information about developmental products, recent developments, and investments in the COVID-19 vaccines and drugs market.Competitive Assessment: In-depth assessment of strategies, products, distribution networks, and manufacturing capabilities of the leading players in the COVID-19 vaccines and drugs market.Key Topics Covered
1 Introduction
1.1 COVID-19 Health Assessment
1.2 COVID-19 Economic Assessment
1.3 COVID-19 Impact on the Economy – Scenario AssessmentCompanies Mentioned
AbbvieCytodynF. Hoffmann-La Roche Ltd.FujifilmGilead Sciences Inc.GlaxoSmithKline plcJanssen Pharmaceuticals Inc.Johnson & Johnson Services Inc.MasterlekMerck KGaAOncoimmunePfizer Inc.Regeneron PharmaceuticalsRidgeback Biotherapeutics L.P.RocheSanofiThe National Institute of Respiratory Diseases (Mexico)For more information about this report visit https://www.researchandmarkets.com/r/y33az2Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900